About this trial
The objectives of the proposed study are to develop and evaluate protocols for ethnic/racial minority-specific research using cancer registry data. In conjunction with the Cancer Registry of Greater California (CRGC), the investigators have developed procedures to identify, recruit, and survey ethnic/racial minority patients with MM. To pilot the study, the investigators aim initially to test the feasibility of this protocol by contacting 400 eligible patients (100 African Americans, 100 Latinos, 100 Asian American/Native Hawaiian/Pacific Islander-AANHPI and 100 non-Hispanic Whites as a comparison group) to conduct a pilot survey through which will ascertain etiological and survival-related factors for MM. Ultimately, the investigators hope the findings from this pilot will yield insight into the best practices for recruiting minorities with MM and serve as the basis for larger population-based studies of MM etiology and survival.
The next phase of this study is to expand the study to all 3 California Cancer Registries, including the Greater Bay Area Cancer Registry and the Los Angeles Cancer Surveillance Program and Cancer Registry of Greater California. We will increase the sample size to recruit atleast 1000 participants per racial/ethnic group. We will also request to increase the scope of the study to also continue a survivorship cohort.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with a first primary pathologically confirmed case of Multiple Myeloma within the previous 5 years
At least 21 years of age at the time of diagnosis
Must have been diagnosed in one of the 48 counties in California
Participant must be alive
Disqualifiers
People who have not been diagnosed with Multiple Myeloma
Under the age of 21
Pregnant
Prisoner
Trial population
We will recruit 4,000 participants (1000 Latinos/ 1000 African Americans/ 1000 Asian American/Native Hawaiian/Pacific Islanders/ 1000 Non-Hispanic Whites). Participants will be randomly selected from cancer registry using the criteria above.
Trial design
Case-control
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Review the response rate of mailed out surveys, compared by race/ethnicity and disease status
Response Rate in percentage
Response rate for saliva kits compared to survey response and determine if there is a disparity in participation between race/ethnic groups
Response Rates in percentage
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of California, Davis
Lead sponsor
Cancer Registry of Greater California
Collaborator